Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory Piazza

Showing results (271-280 of 309) with videos related to

Pageof 31
Sort By:
The American Journal of Medicine|March 21, 2013
Randomized trial of physician alerts for thromboprophylaxis after dischargeGregory Piazza, Frederick A Anderson, Thomas L Ortel, et al.
The American Journal of Medicine|May 29, 2023
Anticoagulation-Associated Adverse Drug Events in Hospitalized Patients Across Two Time PeriodsJohn Fanikos, Yahya Tawfik, Danya Almheiri, et al.
Journal of the American College of Cardiology|October 1, 2025
Fibrinolytic Therapy for Thromboembolic Diseases: Approved Indications and Future DirectionsSina Rashedi, Hannah Leyva, Nada Hamade, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 8, 2025
Direct oral anticoagulants or warfarin in patients with left ventricular thrombus after ST-elevation myocardial infarction: a pilot trial and a prespecified meta-analysis of randomised trialsYaser Jenab, Parham Sadeghipour, Reza Mohseni-Badalabadi, et al.
Medrxiv : the Preprint Server for Health Sciences|May 11, 2021
Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized TrialsAzita H Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, et al.
Journal of the American College of Cardiology|October 15, 2021
Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19: JACC State-of-the-Art ReviewAzita H Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, et al.
JAMA Cardiology|October 19, 2022
Catheter-Directed Thrombolysis vs Anticoagulation in Patients With Acute Intermediate-High-risk Pulmonary Embolism: The CANARY Randomized Clinical TrialParham Sadeghipour, Yaser Jenab, Jamal Moosavi, et al.
Journal of Vascular and Interventional Radiology : JVIR|June 24, 2017
Evaluation of a Device Combining an Inferior Vena Cava Filter and a Central Venous Catheter for Preventing Pulmonary Embolism Among Critically Ill Trauma PatientsVictor F Tapson, Joshua P Hazelton, John Myers, et al.
Thrombosis and Haemostasis|February 22, 2023
Developing Validated Tools to Identify Pulmonary Embolism in Electronic Databases: Rationale and Design of the PE-EHR+ StudyBehnood Bikdeli, Ying-Chih Lo, Candrika D Khairani, et al.
Thrombosis Research|September 24, 2025
Safety and effectiveness of statins in hospitalized patients with COVID-19: Systematic review and collaborative meta-analysis of randomized controlled trialsLuis Ortega-Paz, Azita H Talasaz, Parham Sadeghipour, et al.
Pageof 31

Showing results (271-280 of 309) with videos related to

Sort By:
Pageof 31
The American Journal of Medicine|March 21, 2013
Randomized trial of physician alerts for thromboprophylaxis after dischargeGregory Piazza, Frederick A Anderson, Thomas L Ortel, et al.
The American Journal of Medicine|May 29, 2023
Anticoagulation-Associated Adverse Drug Events in Hospitalized Patients Across Two Time PeriodsJohn Fanikos, Yahya Tawfik, Danya Almheiri, et al.
Journal of the American College of Cardiology|October 1, 2025
Fibrinolytic Therapy for Thromboembolic Diseases: Approved Indications and Future DirectionsSina Rashedi, Hannah Leyva, Nada Hamade, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 8, 2025
Direct oral anticoagulants or warfarin in patients with left ventricular thrombus after ST-elevation myocardial infarction: a pilot trial and a prespecified meta-analysis of randomised trialsYaser Jenab, Parham Sadeghipour, Reza Mohseni-Badalabadi, et al.
Medrxiv : the Preprint Server for Health Sciences|May 11, 2021
Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized TrialsAzita H Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, et al.
Journal of the American College of Cardiology|October 15, 2021
Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19: JACC State-of-the-Art ReviewAzita H Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, et al.
JAMA Cardiology|October 19, 2022
Catheter-Directed Thrombolysis vs Anticoagulation in Patients With Acute Intermediate-High-risk Pulmonary Embolism: The CANARY Randomized Clinical TrialParham Sadeghipour, Yaser Jenab, Jamal Moosavi, et al.
Journal of Vascular and Interventional Radiology : JVIR|June 24, 2017
Evaluation of a Device Combining an Inferior Vena Cava Filter and a Central Venous Catheter for Preventing Pulmonary Embolism Among Critically Ill Trauma PatientsVictor F Tapson, Joshua P Hazelton, John Myers, et al.
Thrombosis and Haemostasis|February 22, 2023
Developing Validated Tools to Identify Pulmonary Embolism in Electronic Databases: Rationale and Design of the PE-EHR+ StudyBehnood Bikdeli, Ying-Chih Lo, Candrika D Khairani, et al.
Thrombosis Research|September 24, 2025
Safety and effectiveness of statins in hospitalized patients with COVID-19: Systematic review and collaborative meta-analysis of randomized controlled trialsLuis Ortega-Paz, Azita H Talasaz, Parham Sadeghipour, et al.
Pageof 31